CSF2 and cancer: On the other hand, moDCs are routinely generated in vitro from monocytes in presence of granulocyte–macrophage colony stimulating factor (GM-CSF, CSF-2) and interleukin4 (IL4) and are often utilized under clinical settings to perform immunotherapies against cancer [17].